Memorial Sloan Kettering medical oncologist Pedram Razavi

Pedram Razavi, MD, PhD

Areas of Expertise

Conditions I Treat

  • Breast cancers and conditions
  • Hereditary cancers

My Specialties

  • Liquid biopsy
  • Precision medicine
Request an Appointment
Our Care Advisors can answer many of your questions. They will connect you with the best healthcare provider for your needs.
English
Share

Get to Know Me

I am a board-certified medical oncologist and physician-scientist focused on personalized care for people with breast cancer. I work closely with an exceptional team of surgeons, radiation oncologists, and nurses to provide the best care to my patients and their families.

Read more

My research focuses on cancer genomics to understand the reasons behind the resistance or response to therapy and ultimately to develop molecular biomarkers to guide precision medicine. I am developing liquid biopsy assays (circulating tumor DNA assays) to precisely detect tumor genomic changes in blood samples. This information may help us monitor the extent of the disease and its heterogeneity, predict a person’s response to treatment, and detect early-stage and minimal residual disease. My ultimate goal is to use the insights gained from these studies to develop new treatment strategies for people with breast cancer.

What I Do at MSK

I'm a breast medical oncologist, which is a cancer doctor who specializes in breast cancer.

  • Director of Liquid Biopsy & Genomics
Areas of Expertise

Conditions I Treat

  • Breast cancers and conditions
  • Hereditary cancers

My Specialties

  • Liquid biopsy
  • Precision medicine
Education & Honors

Education

  • MD, Tehran University of Medical Sciences
  • MPH, University of Southern California
  • PhD, University of Southern California

Residencies

  • Internal Medicine - University of Southern California

Fellowships

  • Medical Oncology - Memorial Sloan Kettering Cancer Center

Board Certifications

  • Medical Oncology
  • Internal Medicine

Awards and Honors

  • Breast Cancer Alliance Young Investigator Award
  • Susan G. Komen Career Catalyst Research Award
  • Finalist, Damon Runyon Clinical Investigator Award

Insurance Information

Understanding your insurance options is an important part of managing your cancer care. We have relationships with many common healthcare providers and plans.

Don't see your carrier or plan? We can help you understand your coverage.

If you don't have health insurance or are worried that your care may not be fully covered, our financial assistance programs may be able to help.

If you have questions about insurance, call us at 646-497-9176.

Make an Appointment

Current Patients
Request an appointment by logging in to MSK MyChart or calling your Care Team. If you are not enrolled in MSK MyChart, ask your Care Team to send you an invitation. You can also go to MSK MyChart and select “Sign up now.”

Contact and Location

Dr. Razavi sees patients at one location.

Office Phone
Location
New York, NY
300 East 66th Street Floors 1 - 4 New York NY 10065

Looking to see a doctor at a different location? See all MSK locations.

Colleagues

Doctors at Memorial Sloan Kettering work as teams, with specialists from all different areas. This allows us to consider all your needs together, and to give you the best possible care.

See all Breast Medicine Service doctors

Clinical Trials

Smiling doctors in the lab
Find a Clinical Trial for You

Memorial Sloan Kettering's doctors and scientists are constantly developing new treatments for cancer. MSK is typically running hundreds of clinical trials at a given time.

You may be able to participate in a clinical trial even if you are new to MSK. Search our online directory to find trial information and see more about who can participate.

Search clinical trials

Research and Publications

Publications on PubMed

Visit PubMed for a full listing of Dr. Razavi’s journal articles. Pubmed is an online index of research papers and other articles from the US National Library of Medicine and the National Institutes of Health.

See all on PubMed

Disclosures

Doctors and faculty members often work with pharmaceutical, device, biotechnology, and life sciences companies, and other organizations outside of MSK, to find safe and effective cancer treatments, to improve patient care, and to educate the health care community.

MSK requires doctors and faculty members to report (“disclose”) the relationships and financial interests they have with external entities. As a commitment to transparency with our community, we make that information available to the public.

Pedram Razavi discloses the following relationships and financial interests:

  • AstraZeneca
    Professional Services and Activities
  • Biovica Inc.
    Professional Services and Activities
  • Guardant Health, Inc.
    Professional Services and Activities (Uncompensated)
  • Inivata, Inc.
    Professional Services and Activities
  • Lilly Oncology
    Professional Services and Activities (Uncompensated)
  • Novartis
    Professional Services and Activities
  • Odyssey Biosciences
    Equity; Fiduciary Role / Position; Intellectual Property Rights
  • Paige.AI, Inc.
    Professional Services and Activities (Uncompensated)
  • Prelude Therapeutics
    Professional Services and Activities
  • Regor Pharmaceuticals Inc.
    Professional Services and Activities
  • SAGA Diagnostics
    Professional Services and Activities
  • Tempus Labs, Inc.
    Professional Services and Activities (Uncompensated)

If you’re a patient at MSK and would like more information about your doctor’s external relationships, please talk with your doctor.

The information published here is a complement to other publicly reported data and is for a specific annual disclosure period. There may be differences between information on this and other public sites as a result of different reporting periods and/or the various ways relationships and financial interests are categorized by organizations that publish such data.


This page and data include information for a specific MSK annual disclosure period (January 1, 2023 through disclosure submission in spring 2024). This data reflects interests that may or may not still exist. This data is updated annually.

Learn more about MSK’s COI policies here. For questions regarding MSK’s COI-related policies and procedures, email MSK’s Compliance Office at [email protected].


View all disclosures